p16-Cdk4-Rb axis controls sensitivity to a cyclin-dependent kinase inhibitor PD0332991 in glioblastoma xenograft cells
Ling Cen(Nationwide Children's Hospital), Jann N. Sarkaria(Mayo Clinic in Arizona), Todd Waldman(Georgetown University), J.-S. Kim(Mayo Clinic), Brett L. Carlson(University of California, San Francisco), Stephanie Fink(Mayo Clinic), Paul A. Decker(University of California, San Francisco), A. C. Mladek(Mayo Clinic), Mark A. Schroeder(MACOM (United States)), G. Kitange(Mayo Clinic), Wenting Wu(East China Normal University), Robert B. Jenkins(Mayo Clinic), J. L. Ostrem(Mayo Clinic)
Cited by 187
Related Papers
<i>TP53</i> and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
|New England Journal of Medicine|2016|783
Genetic determinants of p53-induced apoptosis and growth arrest.
|Genes & Development|1996|466
Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts
|Neuro-Oncology|2008|387
Drivers, trends, and potential impacts of long-term coastal reclamation in China from 1985 to 2010
|Estuarine Coastal and Shelf Science|2016|333